A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : CBMN

Search Conditions:
Search Keyword : CBMN
Search Method : Exact match.
Research Area:

Abbreviation: CBMN
Appearance Frequency: 462 time(s)
Long forms: 8

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
cytokinesis-block micronucleus
(451 times)
Environmental Health
(100 times)
MN (133 times)
CA (34 times)
NDI (31 times)
1992 Conversion of excision-repairable DNA lesions to micronuclei within one cell cycle in human lymphocytes.
cytokinesis-block micronucleus cytome assay
(3 times)
(1 time)
BMCyt (1 time)
GS (1 time)
NBUD (1 time)
2012 Effects of unconjugated bilirubin on chromosomal damage in individuals with Gilbert's syndrome measured with the micronucleus cytome assay.
cytokinesis-block MN
(3 times)
Cardiovascular Diseases
(1 time)
MN (2 times)
PBLs (2 times)
ACS (1 time)
2020 Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations.
community-based medical neighborhood
(1 time)
Public Health
(1 time)
CHECK (1 time)
SSRD (1 time)
2019 Development of a Community-Based Medical Neighborhood for Children with Chronic Conditions.
cord blood mononuclear
(1 time)
(1 time)
--- 2004 Nuclear trafficking of macromolecules by an oligopeptide derived from Vpr of human immunodeficiency virus type-1.
cutaneous branch of the mylohyoid nerve
(1 time)
(1 time)
--- 2009 Clinical and anatomical aspects of possible mylohyoid nerve injury during genioplasties.
cytochalasin B-modulated micronucleus
(1 time)
Environmental Health
(1 time)
BN (1 time)
1999 Change in centromeric and acentromeric micronucleus frequencies in human populations after chronic radiation exposure.
cytokinesis-block in vitro micronucleus
(1 time)
Environmental Health
(1 time)
CA (1 time)
2009 Concordance analysis of an in vitro micronucleus screening assay and the regulatory chromosome aberration assay using pharmaceutical drug candidates.